Catheter Precision, Inc. financial data

Symbol
VTAK on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
1670 Highway 160 West, Suite 205, Fort Mill, SC
State of incorporation
DE
Fiscal year end
December 31
Former names
Ra Medical Systems, Inc. (to 8/15/2023)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 71.1 % -74.4%
Quick Ratio 1.85 % -14.4%
Debt-to-equity 89.5 % +104%
Return On Equity -116 % +57.8%
Return On Assets -61.2 % +68%
Operating Margin -2.7K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.27M shares +22.4%
Common Stock, Shares, Outstanding 8M shares +1039%
Entity Public Float 3.9M USD -2.5%
Common Stock, Value, Issued 0 USD

Income Statement

Label TTM Value / Value Unit Change %
Revenues 399K USD -27.8%
Revenue from Contract with Customer, Excluding Assessed Tax 85K USD +844%
Cost of Revenue 38K USD +65.2%
Research and Development Expense 272K USD -42.7%
Operating Income (Loss) -11.2M USD +85.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -70.6M USD -163%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -16.6M USD +76.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.87M USD -19.4%
Cash, Cash Equivalents, and Short-term Investments 11.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 70K USD -48.9%
Inventory, Net 33K USD -25%
Assets, Current 3.29M USD -20.9%
Property, Plant and Equipment, Net 91K USD +30%
Operating Lease, Right-of-Use Asset 105K USD -41.3%
Goodwill 0 USD
Other Assets, Noncurrent 8K USD 0%
Assets 27.8M USD -9.65%
Accounts Payable, Current 230K USD -50.4%
Employee-related Liabilities, Current 35K USD -18.6%
Accrued Liabilities, Current 1.55M USD -10.7%
Liabilities, Current 2.09M USD -15.7%
Deferred Income Tax Liabilities, Net 3.14M USD
Operating Lease, Liability, Noncurrent 13K USD -86.6%
Liabilities 16M USD +67.8%
Retained Earnings (Accumulated Deficit) -292M USD -6.04%
Stockholders' Equity Attributable to Parent 11.8M USD -44.5%
Liabilities and Equity 27.8M USD -9.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.94M USD +83.9%
Net Cash Provided by (Used in) Financing Activities -110K USD -101%
Net Cash Provided by (Used in) Investing Activities -22K USD 0%
Common Stock, Shares Authorized 30M shares 0%
Common Stock, Shares, Issued 8M shares +1039%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.07M USD +43%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.27M USD -77.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3K USD -98.3%
Deferred Tax Assets, Valuation Allowance 11M USD -46.6%
Deferred Tax Assets, Gross 13.3M USD -50.1%
Operating Lease, Liability 111K USD -41%
Depreciation 65K USD +103%
Payments to Acquire Property, Plant, and Equipment 22K USD -40.5%
Lessee, Operating Lease, Liability, to be Paid 112K USD
Property, Plant and Equipment, Gross 188K USD +84.3%
Operating Lease, Liability, Current 98K USD +7.69%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14K USD -82.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 98K USD +2.08%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14K USD -82.7%
Deferred Tax Assets, Operating Loss Carryforwards 12.4M USD -50.2%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14K USD
Additional Paid in Capital 304M USD +2.43%
Amortization of Intangible Assets 2M USD 0%
Share-based Payment Arrangement, Expense 1.22M USD +172%
Interest Expense 32K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%